Language:
English
繁體中文
KMU OLIS
Login
Back
Switch To:
Labeled
|
MARC Mode
|
ISBD
Pharmaceutical industryinnovation an...
~
Mancuso, David A.
Pharmaceutical industryinnovation and developments /
Record Type:
Language materials, printed : Monograph/item
Title/Author:
Pharmaceutical industry/ David A. Mancuso and Isobel M. Grenada, editors.
Reminder of title:
innovation and developments /
other author:
Mancuso, David A.
Published:
Hauppauge, N.Y. :Nova Science, : c2011.,
Description:
1 online resource (ix, 182 p.) :ill. :
Subject:
Drug development. -
Online resource:
http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=382402
ISBN:
9781621004394 (electronic bk.)
Pharmaceutical industryinnovation and developments /
Pharmaceutical industry
innovation and developments /[electronic resource] :David A. Mancuso and Isobel M. Grenada, editors. - Hauppauge, N.Y. :Nova Science,c2011. - 1 online resource (ix, 182 p.) :ill. - Business issues, competition and entrpreneurship. - Business issues, competition and entrepreneurship series..
Includes bibliographical references and index.
Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R & D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R & D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO.
ISBN: 9781621004394 (electronic bk.)Subjects--Topical Terms:
232902
Drug development.
Index Terms--Genre/Form:
228523
Electronic books.
LC Class. No.: RM301.25 / P428 2011eb
Dewey Class. No.: 615/.19
National Library of Medicine Call No.: QV 736
Pharmaceutical industryinnovation and developments /
LDR
:02284cam 2200385Ka 4500
001
248645
003
OCoLC
005
20120625232956.0
006
m d
007
cr cnu---unuuu
008
120712s2011 nyua ob 001 0 eng d
020
$a
9781621004394 (electronic bk.)
020
$a
1621004392 (electronic bk.)
020
$z
9781612093949
020
$z
1612093949
035
$a
(OCoLC)750642412
035
$a
ocn750642412
040
$a
N$T
$b
eng
$c
N$T
$d
OCLCQ
049
$a
KMCA
050
4
$a
RM301.25
$b
P428 2011eb
060
4
$a
QV 736
072
7
$a
MED
$x
023000
$2
bisacsh
072
7
$a
MED
$x
058170
$2
bisacsh
072
7
$a
MED
$x
071000
$2
bisacsh
072
7
$a
MED
$x
072000
$2
bisacsh
082
0 4
$a
615/.19
$2
22
245
0 0
$a
Pharmaceutical industry
$h
[electronic resource] :
$b
innovation and developments /
$c
David A. Mancuso and Isobel M. Grenada, editors.
260
$a
Hauppauge, N.Y. :
$c
c2011.
$b
Nova Science,
300
$a
1 online resource (ix, 182 p.) :
$b
ill.
490
1
$a
Business issues, competition and entrpreneurship
504
$a
Includes bibliographical references and index.
505
0
$a
Authorized generic pharmaceuticals : effects on innovation / John R. Thomas -- Authorized generics : an interim report / FTC -- Remarks of J. Thomas Rosch, Commissioner, Federal Trade Commission, before the World Generic Medicine Congress, hearing on "pay-for-delay settlements, authorized generics, and follow-on biologies : thoughts on the how competition law can best protect consumer welfare in the pharmaceutical context" -- Federal R & D, drug discovery, and pricing : insights from the NIH-university-industry relationship / Wendy H. Schacht -- Pharmaceutical R & D and the evolving market for prescription drugs / CBO -- Federal taxation of the drug industry and its effects on new drug development / Gary Guenther -- Pharmaceutical patent litigation settlements : implications for competition and innovation / John R. Thomas -- FDA's authority to regulate drug compounding : a legal analysis / Jennifer Staman -- Promotional spending for prescription drugs / CBO.
588
$a
Description based on print version record.
650
0
$2
96060
$a
Drug development.
$3
232902
650
0
$2
96060
$a
Pharmaceutical industry.
$3
253879
650
0
$a
Drugs
$x
Law and legislation.
$3
310608
650
2
$a
Drug Industry
$x
economics.
$3
322651
650
2
$a
Drug Industry
$x
legislation & jurisprudence.
$3
311172
650
2
$a
Drug Discovery
$x
economics.
$3
322652
650
2
$a
Drugs, Generic
$x
economics.
$3
322653
650
7
$a
MEDICAL
$x
Drug Guides.
$2
bisacsh
$3
322588
650
7
$a
MEDICAL
$x
Nursing
$x
Pharmacology.
$2
bisacsh
$3
322591
650
7
$a
MEDICAL
$x
Pharmacology.
$2
bisacsh
$3
322589
650
7
$a
MEDICAL
$x
Pharmacy.
$2
bisacsh
$3
322590
655
4
$a
Electronic books.
$2
local
$3
228523
700
1
$a
Mancuso, David A.
$3
322648
700
1
$a
Grenada, Isobel M.
$3
322649
830
0
$a
Business issues, competition and entrepreneurship series.
$3
322650
856
4 0
$3
EBSCOhost
$u
http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=382402
994
$a
92
$b
KMC
999
$z
634762210347752051
based on 0 review(s)
Multimedia
Reviews
Add a review
and share your thoughts with other readers
Export
pickup library
Processing
...
Change password
Login